Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Canadian Importation Option May Be Hindered By Product, Savings Restrictions

Jul 31 2019

• By Derrick Gingery

Drug costs_1B_546120055_1200.jpg — Biologics and other products could not be imported from Canada under existing law. • Source: Shutterstock

Related Content

Mylan/Biocon’s Insulin Glargine Has Narrow Window For Approval In US

Jul 10 2019

FDA Announces Launch Of DSCSA Supply Chain Security Pilot Program

Feb 08 2019

Survey Shows Drug Makers Don't Expect To Begin Serializing All Packages By November Deadline

Oct 20 2018

Rx Importation: Califf's Switch Means US FDA Commissioners No Longer Uniformly Opposed

Apr 24 2019

Acting US FDA Chief Sharpless Pledges "Full Speed Ahead" On Agency's Current Agenda

Apr 16 2019

Additional Topics

United States Pricing Debate Legal Issues Regulation FDA BioPharmaceutical

More from Pricing Debate

More from Market Access

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window